Medikaloka Hermina PT (HEAL) - Net Assets

Latest as of June 2025: Rp7.01 Trillion IDR ≈ $410.97 Million USD

Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has net assets worth Rp7.01 Trillion IDR (≈ $410.97 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp11.92 Trillion ≈ $698.61 Million USD) and total liabilities (Rp4.91 Trillion ≈ $287.64 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HEAL tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp7.01 Trillion
% of Total Assets	58.83%
Annual Growth Rate	22.31%
5-Year Change	73.45%
10-Year Change	N/A
Growth Volatility	44.96

Medikaloka Hermina PT - Net Assets Trend (2015–2024)

This chart illustrates how Medikaloka Hermina PT's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Medikaloka Hermina PT to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Medikaloka Hermina PT (2015–2024)

The table below shows the annual net assets of Medikaloka Hermina PT from 2015 to 2024. For live valuation and market cap data, see Medikaloka Hermina PT (HEAL) market capitalisation.

Year	Net Assets	Change
2024-12-31	Rp5.87 Trillion ≈ $343.74 Million	+12.85%
2023-12-31	Rp5.20 Trillion ≈ $304.60 Million	+10.95%
2022-12-31	Rp4.69 Trillion ≈ $274.55 Million	+6.82%
2021-12-31	Rp4.39 Trillion ≈ $257.02 Million	+29.69%
2020-12-31	Rp3.38 Trillion ≈ $198.18 Million	+22.35%
2019-12-31	Rp2.76 Trillion ≈ $161.98 Million	+16.66%
2018-12-31	Rp2.37 Trillion ≈ $138.86 Million	+147.74%
2017-12-31	Rp956.53 Billion ≈ $56.05 Million	-24.08%
2016-12-31	Rp1.26 Trillion ≈ $73.83 Million	+31.58%
2015-12-31	Rp957.59 Billion ≈ $56.11 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Medikaloka Hermina PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2257.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	Rp2.83 Trillion	63.49%
Common Stock	Rp307.32 Billion	6.90%
Other Comprehensive Income	Rp-470.59 Billion	-10.57%
Other Components	Rp1.79 Trillion	40.17%
Total Equity	Rp4.45 Trillion	100.00%

Medikaloka Hermina PT Competitors by Market Cap

The table below lists competitors of Medikaloka Hermina PT ranked by their market capitalization.

Company	Market Cap
Life Healthcare JSE:LHC	$797.02 Million
Alto Neuroscience, Inc. NYSE:ANRO	$797.10 Million
Aucma Co Ltd SHG:600336	$797.57 Million
Samsung Fire And Marine Ins Pref KO:000815	$797.67 Million
Mesnac Co Ltd SHE:002073	$796.82 Million
Westlake Chemical Partners LP NYSE:WLKP	$796.56 Million
SHENWAN HONGYUAN GR.H YC1 F:2X2A	$796.26 Million
Puyang Huicheng Electronic Material Co Ltd SHE:300481	$796.07 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medikaloka Hermina PT's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 3,869,118,000,000 to 4,451,977,000,000, a change of 582,859,000,000 (15.1%).
Net income of 535,942,000,000 contributed positively to equity growth.
Dividend payments of 126,565,000,000 reduced retained earnings.
Share repurchases of 167,650,000,000 reduced equity.
New share issuances of 167,650,000,000 increased equity.
Other comprehensive income decreased equity by 43,186,000,000.
Other factors increased equity by 216,668,000,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Rp535.94 Billion	+12.04%
Dividends Paid	Rp126.56 Billion	-2.84%
Share Repurchases	Rp167.65 Billion	-3.77%
Share Issuances	Rp167.65 Billion	+3.77%
Other Comprehensive Income	Rp-43.19 Billion	-0.97%
Other Changes	Rp216.67 Billion	+4.87%
Total Change	Rp-	15.06%

Book Value vs Market Value Analysis

This analysis compares Medikaloka Hermina PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.95x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 14.07x to 2.95x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2015-12-31	Rp62.88	Rp885.00	x
2016-12-31	Rp82.85	Rp885.00	x
2017-12-31	Rp35.96	Rp885.00	x
2018-12-31	Rp132.95	Rp885.00	x
2019-12-31	Rp142.31	Rp885.00	x
2020-12-31	Rp171.44	Rp885.00	x
2021-12-31	Rp219.27	Rp885.00	x
2022-12-31	Rp237.06	Rp885.00	x
2023-12-31	Rp262.97	Rp885.00	x
2024-12-31	Rp299.96	Rp885.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medikaloka Hermina PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 12.04%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.96%
• Asset Turnover: 0.64x
• Equity Multiplier: 2.38x
Recent ROE (12.04%) is below the historical average (13.93%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	2.13%	1.13%	0.96x	1.97x	Rp-71.20 Billion
2016	5.20%	2.77%	0.89x	2.10x	Rp-57.24 Billion
2017	21.47%	3.64%	0.80x	7.37x	Rp52.12 Billion
2018	6.67%	4.07%	0.73x	2.24x	Rp-62.21 Billion
2019	16.02%	9.47%	0.72x	2.35x	Rp129.20 Billion
2020	25.30%	14.62%	0.69x	2.49x	Rp390.43 Billion
2021	30.47%	17.11%	0.77x	2.32x	Rp669.06 Billion
2022	8.68%	6.09%	0.65x	2.21x	Rp-45.49 Billion
2023	11.30%	7.56%	0.66x	2.28x	Rp50.43 Billion
2024	12.04%	7.96%	0.64x	2.38x	Rp90.74 Billion

Industry Comparison

This section compares Medikaloka Hermina PT's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $4,309,669,705,296
Average return on equity (ROE) among peers: 14.42%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Medikaloka Hermina PT (HEAL)	Rp7.01 Trillion	2.13%	0.70x	$796.84 Million
Bundamedik Tbk PT (BMHS)	$1.81 Trillion	7.13%	0.63x	$92.26 Million
Metro Healthcare Indonesia (CARE)	$2.27 Trillion	-1.06%	0.08x	$806.60 Million
Lippo Karawaci Tbk (LPKR)	$22.08 Trillion	4.00%	1.07x	$257.49 Million
Mitra Keluarga Karyasehat Tbk PT (MIKA)	$7.33 Trillion	15.64%	0.13x	$1.30 Billion
Royal Prima PT (PRIM)	$12.13 Billion	95.19%	2.15x	$17.22 Million
Kedoya Adyaraya Tbk PT (RSGK)	$751.16 Billion	3.35%	0.10x	$47.12 Million
Sarana Meditama Metropolitan (SAME)	$850.97 Billion	1.74%	0.71x	$299.72 Million
Siloam International Hospitals (SILO)	$3.13 Trillion	2.75%	0.35x	$1.65 Billion
Sejahteraraya Anugrahjaya Tbk (SRAJ)	$556.74 Billion	1.08%	0.31x	$7.89 Billion

About Medikaloka Hermina PT

JK:HEAL Indonesia Medical Care Facilities

Market Cap

$796.84 Million

Rp13.60 Trillion IDR

Market Cap Rank

#10092 Global

#98 in Indonesia

Share Price

Rp885.00

Change (1 day)

+1.72%

52-Week Range

Rp770.00 - Rp1760.00

All Time High

Rp971874.91